Patient-reported cognition at the end of a PCSK9 antibody trial
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- MinuteCE®
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
0.75 program creditsJulia Brandts, MD
Pasquale Perrone-Filardi, MD, PhD
Prof. Alberto Zambon MD, PhD, FAHA
Prof. Kausik Ray, MBChB, MD, MPhil
Azfar Zaman, MD
- MinuteCE®
Understanding the role of triglycerides in the assessment of residual risk
0.50 program creditsProf. Alberto Zambon MD, PhD, FAHA